Merck KGaA’s new R&D strategy is continuing to run apace, with the company ramping up efforts to more swiftly sign onto and offload assets that have commercial potential.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,